Articles
Now Hiring | Linear Capital's Investment Team Is Still Growing — Enterprise Software, Biotech, and Hard Tech Roles Open
**1. Principal, Senior Principal — Enterprise Services, Biotech/Healthcare, Deep Tech/Hard Tech, and related verticals**
A Conversation with Dreame's Yu Hao: I Was Born a Madman
In an era when experience no longer holds sway, the order in which you appear on stage no longer matters.
5Y News | 5Y Capital Portfolio Company *Deepexi* Closes Series B+ Round
Focused on lakehouse-integrated data intelligence infrastructure software.
Robots, AI, and Simulation Technologies Accelerate Industrial Adoption | Rongbao · June
Technology drives industrial transformation.
July: Seeking Vast Possibilities | 5Y News Monthly
The big news from last month.
Linear Capital Perspectives | AI Enters Industry: Is the Current Moment a Window of Opportunity or a Bubble, and Which Investment Areas Does Linear Capital Favor?
In late June, Harry Wang, founder and CEO of Linear Capital, was invited to speak at the Amazon Web Services (AWS) Innovation Conference, where he joined Dr. Zhang Xia, chief enterprise strategy advisor at AWS, for a conversation on recent AI investment insights. Wang shared Linear Capital's analysis of AI's integration into industries, the firm's investment focus areas, the technical bottlenecks that need to be overcome in the next phase, and related recommendations. Below is a summary of the conversation, with both video and transcript.
Linear Capital Leads Series A in Jingshuo Technology, Which Closes Two Rounds Worth RMB 130 Million Within a Year; Linear Doubles Down With Follow-On Lead
Less than a year after raising 80 million RMB in its Series A last June, marketing technology company JINGdigital has closed an additional 50 million RMB in its Series A+ round, bringing the total raised across both rounds to 130 million RMB.
Internship Openings | HR, Legal, and Marketing Roles Available — Send Us Your Resume
- Followed up on recruitment processes including resume sourcing, interview scheduling, and feedback collection
5Y News | Helixon Pharma Closes Nearly 500 Million Yuan Series A to Deepen AI-Powered Drug Discovery
Building a life-science platform powered by artificial intelligence.
5Y Capital and Multiple Portfolio Founders Win Multiple Awards from 36Kr and *Fortune* Magazine | 5Y News
5Y Capital continues to seek out, support, and stand by the rarest founders.